Pimavanserin Tartrate Market

Pimavanserin Tartrate Market Size, Share & Industry Analysis, By Source (Chemical Synthesis, Contract Manufacturing [CDMO-Based Synthesis], Multi-Step Organic Intermediates, Hybrid Synthesis [Synthetic + Biological]), By Formulation Type (Oral Tablets, Capsule Formulations), By End-User Industry (Pharmaceuticals, Neurology & Psychiatry Clinics, Hospitals & Mental Health Institutions, Contract Manufacturing Organizations, Research & Development Institutes), and Forecast, 2025–2035

The global Pimavanserin Tartrate market is projected to grow at a CAGR of 6.6% during the forecast period, driven by its rising use in treating Parkinson’s disease psychosis and its emerging role in managing neuropsychiatric disorders such as schizophrenia and dementia-related hallucinations. Pimavanserin Tartrate, a tartrate salt form of Pimavanserin, acts as a selective serotonin 5-HT2A inverse agonist, offering antipsychotic efficacy without dopaminergic side effects, making it a novel therapeutic option in neuropharmacology.

Regionally, North America currently leads the market, supported by the high prevalence of neurodegenerative disorders, robust clinical research infrastructure, and FDA approvals favoring its use in mental health treatment. The Asia-Pacific region is expected to witness the fastest growth, driven by an expanding geriatric population, increasing investments in neurological care, and rising awareness of mental health conditions across countries like Japan, India, and China. Europe also holds a significant share due to strong regulatory support and growing demand for non-traditional antipsychotics.

The Pimavanserin Tartrate market report delivers deep insights into sourcing methods, patent status, clinical pipeline updates, and evolving manufacturing trends. As a key active pharmaceutical ingredient in oral antipsychotic therapies, its demand across pharmaceutical firms, research institutions, and mental health clinics underscores its critical value in advancing next-generation psychiatric treatment options globally.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Pimavanserin Tartrate
  • Key End-Users & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
    • Chemical Synthesis
    • Multi-Step Organic Intermediates
    • Hybrid Synthesis
  • Key End-User Industry
  • Pharmaceuticals
  • Neurology & Psychiatry Clinics
  • Hospitals & Mental Health Institutions
  • Research & Development Institutes

 

  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Trade Analysis
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, and Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Production Capacity
  • Company Profiles & Key Developments
    • ACADIA Pharmaceuticals Inc.
    • Cipla Ltd.
    • Jubilant Ingrevia Limited
    • Amneal Pharmaceuticals
    • Clearsynth Labs Ltd.
    • SimSon Pharma Limited
    • LGM Pharma
    • Angene International Limited
    • Boc Sciences
    • Chemkart
    • Wuhan Fortuna Chemical Co., Ltd.
    • Hangzhou FandaChem Co., Ltd.
    • Manus Aktteva Biopharma LLP
    • TCI Chemicals Pvt. Ltd.
    • Suven Pharmaceuticals Ltd.
    • Aarti Drugs Ltd.
    • Alchem International Pvt. Ltd.
    • Laurus Labs
    • Sai Life Sciences Ltd.
    • Venkatasai Life Sciences Pvt. Ltd.
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is a Pimavanserin Tartrate?
Pimavanserin Tartrate is the tartrate salt form of Pimavanserin, a selective serotonin 5-HT2A receptor inverse agonist used in the treatment of Parkinson’s disease psychosis. It offers antipsychotic benefits without affecting dopaminergic pathways, reducing the risk of motor-related side effects.
What is the market size for Pimavanserin Tartrate?
The Pimavanserin Tartrate market is growing at a CAGR of 6.6% during the forecast period from 2025 to 2035, driven by rising demand for targeted, non-dopaminergic neuropsychiatric treatments.
What are the drivers for the Pimavanserin Tartrate Market?
Key drivers include increasing cases of neurodegenerative diseases, demand for safer antipsychotic therapies, expansion of clinical indications, and regulatory support for innovative psychiatric drugs.
Who are the key players operating in the Pimavanserin Tartrate Market?
Major players include ACADIA Pharmaceuticals, Cipla, Jubilant Ingrevia, Amneal Pharmaceuticals, Clearsynth Labs, SimSon Pharma, and LGM Pharma.
Which region would exhibit the fastest growth in the Pimavanserin Tartrate Market?
The Asia-Pacific region is projected to experience the fastest growth due to rising mental health awareness, aging populations, and increased R&D investments in countries like India, China, and Japan.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.